期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 5, 期 3, 页码 255-258出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml4003293
关键词
HCV; NS5A inhibitor; benzidine; antiviral agent; structure-activity relationship
资金
- Bio R&D Program through National Research Foundation [2012-054974]
- MEST
Here we report the discovery of a series of potent hepatitis C virus (HCV) NS5A inhibitors based on the benzidine prolinamide backbone. Taking a simple synthetic route, we developed a novel inhibitor structure, which allows easy modification, and through optimization of the capping group, we identified compound 6 with highly potent anti-HCV activity. Compound 6 is nontoxic and is anticipated to be an effective HCV drug candidate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据